Literature DB >> 18581146

Reference values of plasma oxalate in children and adolescents.

Tadeusz Porowski1, Walentyna Zoch-Zwierz, Jerzy Konstantynowicz, Agata Korzeniecka-Kozerska, Joanna Michaluk-Skutnik, Halina Porowska.   

Abstract

Oxalate homeostasis is a derivative of absorption and transportation in the digestive system and renal/intestinal excretion of oxalate. The objective of this cross-sectional study was to determine normative values of plasma oxalate in relation to age, gender, and body size. A group of 1,260 healthy Caucasian children and adolescents aged 3 months to 18 years [mean +/- standard deviation (SD) 10.5 +/- 4.3] was studied. Each 1-year group comprised 70 subjects. Oxalate levels were assessed in blood plasma samples obtained from fasted individuals using the precipitation-enzymatic method with oxalate oxidase. Median oxalate levels in healthy infants was 3.20 micromol/L (5th-95th percentiles: 1.56-5.58) and was higher compared with older children [2.50 micromol/L (5th-95th percentiles: 0.95-5.74); p < 0.01]. No differences were found in plasma oxalate levels between boys and girls. There were no associations between plasma oxalate levels and anthropometric traits. In the healthy population aged 1-18 years, plasma oxalate concentration is independent of age, gender, and body size. Infants demonstrate higher plasma oxalate levels compared with older children, which suggests possible immature mechanisms of renal excretion. This study appears to be the first extensive report providing normative data for plasma oxalate in children and adolescents.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18581146     DOI: 10.1007/s00467-008-0889-8

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  56 in total

1.  Discrete analysis of plasma oxalate with alkylamine glass bound sorghum oxalate oxidase and horseradish peroxidase.

Authors:  M Thakur; L Goyal; C S Pundir
Journal:  J Biochem Biophys Methods       Date:  2000-07-10

Review 2.  Dietary therapy in idiopathic nephrolithiasis.

Authors:  Loris Borghi; Tiziana Meschi; Umberto Maggiore; Beatrice Prati
Journal:  Nutr Rev       Date:  2006-07       Impact factor: 7.110

Review 3.  Stones from bowel disease.

Authors:  Elaine M Worcester
Journal:  Endocrinol Metab Clin North Am       Date:  2002-12       Impact factor: 4.741

Review 4.  Oxalic acid metabolism in man: a review.

Authors:  A Hodgkinson; P M Zarembski
Journal:  Calcif Tissue Res       Date:  1968-10-21

5.  Measurement of plasma oxalate in healthy subjects and in patients with chronic renal failure using immobilised oxalate oxidase.

Authors:  G P Kasidas; G A Rose
Journal:  Clin Chim Acta       Date:  1986-01-15       Impact factor: 3.786

6.  New enzymic method for serum oxalate determination.

Authors:  M Hatch; E Bourke; J Costello
Journal:  Clin Chem       Date:  1977-01       Impact factor: 8.327

Review 7.  Dietary influences on urinary oxalate and risk of kidney stones.

Authors:  Linda K Massey
Journal:  Front Biosci       Date:  2003-05-01

8.  [Assessment of oxalate concentration in serum and urine of children with renal stones].

Authors:  Iwona Jadeszko; Tadeusz Porowski; Walentyna M Zoch-Zwierz; Anna M Wasilewska; Lech Hackiewicz
Journal:  Wiad Lek       Date:  2005

9.  Ion-chromatographic determination of plasma oxalate reexamined.

Authors:  M Petrarulo; E Cerelli; M Marangella; F Maglienti; F Linari
Journal:  Clin Chem       Date:  1993-03       Impact factor: 8.327

10.  Establishing a standard definition for child overweight and obesity worldwide: international survey.

Authors:  T J Cole; M C Bellizzi; K M Flegal; W H Dietz
Journal:  BMJ       Date:  2000-05-06
View more
  6 in total

1.  Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones.

Authors:  Kristin J Bergsland; Anna L Zisman; John R Asplin; Elaine M Worcester; Fredric L Coe
Journal:  Am J Physiol Renal Physiol       Date:  2010-12-01

2.  Primary hyperoxaluria in a compound heterozygote infant.

Authors:  Juan Mayordomo-Colunga; Debora Riverol; Eduardo Salido; Fernando Santos
Journal:  World J Pediatr       Date:  2010-06-12       Impact factor: 2.764

3.  Assessment of Plasma Oxalate Concentration in Patients With CKD.

Authors:  Anja Pfau; Monika Wytopil; Kinsuk Chauhan; Martin Reichel; Steve G Coca; Peter S Aronson; Kai-Uwe Eckardt; Felix Knauf
Journal:  Kidney Int Rep       Date:  2020-09-02

Review 4.  Oxalate, inflammasome, and progression of kidney disease.

Authors:  Theresa Ermer; Kai-Uwe Eckardt; Peter S Aronson; Felix Knauf
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

5.  Vitamin C deficiency and impact of vitamin C administration among pediatric patients with advanced chronic kidney disease.

Authors:  Nattaphorn Hongsawong; Notethasoung Chawprang; Kulnipa Kittisakmontri; Parach Vittayananan; Konggrapun Srisuwan; Wattana Chartapisak
Journal:  Pediatr Nephrol       Date:  2020-07-19       Impact factor: 3.714

6.  In vitro and in vivo safety evaluation of Nephure™.

Authors:  Helena Cowley; Qin Yan; Lee Koetzner; Laurie Dolan; Erik Nordwald; Aaron B Cowley
Journal:  Regul Toxicol Pharmacol       Date:  2017-03-18       Impact factor: 3.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.